MAYNE PHARMA GROUP LIMITED

0.40%

$2.51

Market Cap $204.7M

Healthcare Drug Manufacturers - Major

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others. Its subsidiaries include Mayne Pharma International Pty Ltd, Mayne Holdings US Inc, Mayne Pharma LLC, and others.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Latest Threads

Tag

Subject

MYX

DistributeRx

17/04/26

19K

17/04/26

Last post Chartsshout

19K

MYX

Ann: MYX officially opens newly expanded manufacturing facility

2 3

10/04/26

131

25K

10/04/26

Last post KamikazePilot

131

25K

MYX

Ann: MYX expects no material impact from US s232 tariffs

08/04/26

970

08/04/26

Last post monkeybusiness

970

MYX

Ann: Non-Executive Director retirement and recruitment

02/04/26

588

02/04/26

Last post KamikazePilot

588

MYX

Ann: Ceasing to be a substantial holder

02/04/26

1.6K

02/04/26

Last post Chartsshout

1.6K

MYX

Ann: Becoming a substantial holder

27/03/26

743

27/03/26

Last post KamikazePilot

743

MYX

Ann: Mayne Pharma ASX SMIDcaps conference presentation

26/03/26

1.8K

26/03/26

Last post Chartsshout

1.8K

MYX

Ann: Becoming a substantial holder

24/03/26

697

24/03/26

Last post formuso

697

See All Discussions

Timeline

MYX expects no material impact from US s232 tariffs
07 Apr 09:41	Share

Non-Executive Director retirement and recruitment
02 Apr 12:33	Share

Ceasing to be a substantial holder
31 Mar 16:38	Share

Becoming a substantial holder
27 Mar 16:46	Share

Mayne Pharma ASX SMIDcaps conference presentation
25 Mar 11:12	Share

Becoming a substantial holder
24 Mar 17:32	Share

Ceasing to be a substantial holder
23 Mar 16:45	Share

Mayne Pharma to present at ASX SMIDcaps Conference
17 Mar 09:00	Share

DistributeRx Launch Investor Presentation
11 Mar 09:22	Share

Mayne Pharma launches DistributeRx in the US
10 Mar 10:05	Share

Becoming a substantial holder
09 Mar 18:01	Share

S&P DJI Announces March 2026 Quarterly Rebalance
06 Mar 17:05	Share

Becoming a substantial holder
03 Mar 08:26	Share

Ceasing to be a substantial holder from MUFG
02 Mar 18:40	Share

Final Director's Interest Notice (x2)
02 Mar 14:39	Share

Ceasing to be a substantial holder
27 Feb 17:56	Share

Proposed issue of securities - MYX
23 Feb 18:56	Share

Final Director's Interest Notice
23 Feb 18:51	Share

2026 Half Year Investor Presentation
23 Feb 09:38	Share

2026 Half Year Media Release
23 Feb 09:35	Share

Half Yearly Report and Accounts
23 Feb 09:34	Share

Mayne Pharma Management Changes
23 Feb 09:31	Share

Notification of date for release of 1H26 results
19 Feb 14:03	Share

MYX to claim against Cosette, Avista & Mr David Burgstahler
18 Feb 09:35	Share

Ceasing to be a substantial holder
06 Feb 08:18	Share

2025 AGM Results of Meeting
29 Jan 12:09	Share

2025 AGM presentation and business update
29 Jan 09:42	Share

2025 AGM Chair's Address to Shareholders
29 Jan 09:41	Share

Ceasing to be a substantial holder
19 Jan 19:48	Share

Change in substantial holding
19 Jan 09:46	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $2.51		Change -0.010(0.40%)		Mkt cap ! $204.7M

Open	High	Low	Volume
$2.53	$2.58	$2.49	162.6K

Buyers (Bids)

Vol.	Price($)
4515	$2.51

Sellers (Offers)

Price($)	Vol.
$2.58	1163

Last trade - 16.11pm 20/04/2026 (20 minute delay)

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED

Latest Threads

DBO - Further High-Grade Critical Minerals Results Extend Target Zones at Star Range, Utah

Timeline

Featured News

Latest Articles

Mayne Pharma plummets -30% as foreign review board rejects Cosette buyout

Mayne Pharma has revealed a letter from Chalmers has outlined that the gov't (via the FIRB) intends to reject the company's takeover deal.

Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...

Mayne Pharma to pay A$33M in class action settlement on alleged US conduct

Mayne Pharma (ASX:MYX) has announced it will pay A$38M – $4.7M covered by insurance – to settle a class action brought in 2021.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News